Icosagen Acquires the Carterra LSA Instrument to Significantly Enhance Its Antibody Screening Capabilities in the Discovery and Development of New Therapeutic and Diagnostic Antibodies
Read More
Carterra expands best-in-class franchise with the launch of the LSAXT high-throughput SPR biosensor at SLAS 2023
Read More
Ernst and Young Selects Josh Eckman, CEO of Carterra, as 2022 Entrepreneur of the Year Mountain West Award Winner
Read More
La Jolla Institute for Immunology Acquires LSA Platform
Read More
Carterra Joins the Tetra Partner Network to Advance Therapeutics Discovery
Read More
2022 Carterra Symposia
Read More
University of Manchester Adds Carterra’s LSA Instrument for High-Throughput Antibody Screening and Characterization
Read More
Carterra awarded 10 Fastest Growing Life Sciences Companies to Watch in 2022
Read More
Genovac Acquires the Carterra LSA Instrument to Enable State-of-the-Art Antibody Screening and Characterization Services
Read More
Expert View: Transforming biotherapeutic development post-pandemic
Read More
